Skip to main content
. 2020 Oct 9;9:100119. doi: 10.1016/j.eurox.2020.100119

Fig. 5.

Fig. 5

The schematic diagram of dyslipidemia involvement with PE and other CVDs.

The metabolic process of transforming from TG-rich VLDL produced by the liver to other lipoproteins, and the possible mechanisms involved in the development of PE and other CVDs.